Chart of the month
Tue Jun 1, 2004
Castle Creek Lifescience Partners' CCL Fund has considerably
outperformed both the NASDAQ and the Absolute Return Tech index
ISSN: 2151-1845 / CDC10004H
The full contents of this article are available to active AR subscribers and trialists only.
TAKE A FREE TRIAL
To continue reading please, take a free trial, subscribe or log in to AR.
Subscribers have unlimited access to all current and archive content. Start your subscription today - click on the button below.